Research Papers

25 of 52041 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Stereotactic body radiotherapy in lung cancer: a contemporary review.
Csiki E; Simon M; Papp J; Barabás M; Mikáczó J; Gál K; Sipos D; Kovács Á.
Pathol Oncol Res (Unknown)
Published: 2024
2/6 Transparent
UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabil…
Li J; Liang Y; Zhou S; Chen J; Wu C.
Breast Cancer Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer.
Nie X; Gao L; Zheng M; Wang S; Wang C; Li X; Liu O; Gou R; Liu J; Lin B.
BMC Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer.
Mäenpää N; Tiainen L; Hämäläinen M; Luukkaala T; Tanner M; Lahdenperä O; Vihinen P; Karihtala P; Kellokumpu-Lehtinen PL; Moilanen E; Jukkola A.
BMC Cancer (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and the…
Ren X; Cui H; Dai L; Chang L; Liu D; Yan W; Zhao X; Kang H; Ma X.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The influence of marital status at diagnosis on survival of adult patients with mantle cell lymphoma.
Zhang T; Wang ZT; Li Z; Yin SX; Wang X; Chen HZ.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Lymph node metastases in middle and upper mediastinum of Siewert type II adenocarcinoma: A real-world retrospective stu…
Luo P; Chen X; Yang Y; Zhang R; Kang X; Qin J; Qi X; Li Y.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
High TPX2 expression results in poor prognosis, and Sp1 mediates the coupling of the CX3CR1/CXCL10 chemokine pathway to…
Yang M; Mao X; Li L; Yang J; Xing H; Jiang C.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Psychometric validation of the Functional Assessment of Cancer Therapy-Endometrial among endometrial cancer patients.
Kim S; Noh JJ; Kim Y; Cho J; Kang D; Lee YY.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Incidence of skeletal-related events in patients with Ewing sarcoma: An observational retrospective study in Japan.
Aiba H; Kojima Y; Shimoi T; Sudo K; Yazaki S; Imai T; Yoshida A; Iwata S; Kobayashi E; Kawai A; Arakawa A; Ogawa C; Kimura H; Yonemori K.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Personal history of cancer as a risk factor for second primary lung cancer: Implications for lung cancer screening.
Nofal S; Niu J; Resong P; Jin J; Merriman KW; Le X; Katki H; Heymach J; Antonoff MB; Ostrin E; Wu J; Zhang J; Toumazis I.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Survival of the Hmong population diagnosed with colon and rectal cancers in the United States.
Walker MR; Lor K; Lor KB; Vidri RJ; Hampton JM; Maldonado C; Schiefelbein AM; LoConte NK.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery an…
Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression.
Wang J; Wang C; Hu A; Yu K; Kuang Y; Gajendran B; Zacksenhaus E; Sample KM; Xiao X; Liu W; Ben-David Y.
BMC Cancer (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway.
Wang R; Li R; Yang H; Chen X; Wu L; Zheng X; Jin Y.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.
Iachettini S; Terrenato I; Porru M; Di Vito S; Rizzo A; D'Angelo C; Petti E; Dinami R; Maresca C; Di Benedetto A; Palange A; Mulè A; Santoro A; Palazzo A; Fuso P; Stoppacciaro A; Vici P; Filomeno L; Di Lisa FS; Arcuri T; Krasniqi E; Fabi A; Biroccio A; Zizza P.
J Exp Clin Cancer Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarc…
Ge W; Wang Y; Quan M; Mao T; Bischof EY; Xu H; Zhang X; Li S; Yue M; Ma J; Yang H; Wang L; Yu Z; Wang L; Cui J.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis.
Zhao Y; Jia Y; Wang J; Chen X; Han J; Zhen S; Yin S; Lv W; Yu F; Wang J; Xu F; Zhao X; Liu L.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
PErspective and current status of Radiotherapy Service in IRan (PERSIR)-1 study: assessment of current external beam ra…
Saeedian A; Tabatabaei FS; Azimi A; Babaei M; Lashkari M; Esmati E; Abiar Z; Moadabshoar L; Sandoughdaran S; Kamrava M; Amini A; Ghalehtaki R.
BMC Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from …
Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S.
BMC Cancer (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors.
Ding Y; Zhou Q; Ding B; Zhang Y; Shen Y.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The FBXW7-binding sites on FAM83D are potential targets for cancer therapy.
Jiang X; Wang Y; Guo L; Wang Y; Miao T; Ma L; Wei Q; Lin X; Mao JH; Zhang P.
Breast Cancer Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Fully semantic segmentation for rectal cancer based on post-nCRT MRl modality and deep learning framework.
Xia S; Li Q; Zhu HT; Zhang XY; Shi YJ; Yang D; Wu J; Guan Z; Lu Q; Li XT; Sun YS.
BMC Cancer (Unknown)
Published: 2024
4/6 Transparent
Code Funding Declared
Stories to Prevent Cancer: A Pilot Study Using Cancer Survivor Narratives to Increase Human Papillomavirus Vaccine Inte…
Bufalini CM; Kraschnewski JL; Riley TD; Wile K; Spanos K; Wong A; Myrick JG; Schaefer EW; Calo WA.
Cancer Control (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A Pilot Study of Pembrolizumab Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastati…
Harris JP; Park J; Ku E; Seyedin S; Stitzlein R; Goldin A; Chen WP; McLaren C; Chen AM; Chow W.
Cancer Control (Unknown)
Published: 2024
3/6 Transparent
Funding Declared